President and CEO of Exact Sciences Corp (EXAS, Financial) Kevin T Conroy sold 600,000 shares of EXAS on 11/15/2016 at an average price of $17.46 a share. The total sale was $10.5 million.
Exact Sciences Corp is a molecular diagnostics company currently focused on the early detection and prevention of colorectal cancer. It has developed a nonāāinvasive, patient friendly screening test called Cologuard(R). Exact Sciences Corp has a market cap of $1.89 billion; its shares were traded at around $17.41 with and P/S ratio of 21.96. Exact Sciences Corp had an annual average EBITDA growth of 13.90% over the past 10 years.
CEO Recent Trades:
- President and CEO Kevin T Conroy sold 600,000 shares of EXAS stock on 11/15/2016 at the average price of $17.46. The price of the stock has decreased by 0.29% since.
Directors and Officers Recent Trades:
- Chief Science Officer Graham Peter Lidgard sold 311,112 shares of EXAS stock on 11/15/2016 at the average price of $17.46. The price of the stock has decreased by 0.29% since.
- COO Maneesh Arora sold 562,932 shares of EXAS stock on 11/15/2016 at the average price of $17.46. The price of the stock has decreased by 0.29% since.
For the complete insider trading history of EXAS, click here
.
